Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in Egypt.
作者信息
Spencer Brooke, Banerjee Mousumi, Omar Sherif, Khaled Hussein, Anwar Nayera, Zaghloul Mohamed S, Eissa Saad, Kleer Celina G, Dey Subhojit, Merajver Sofia D, Soliman Amr S
出版信息
Breast J. 2011 Sep-Oct;17(5):545-7. doi: 10.1111/j.1524-4741.2011.01146.x. Epub 2011 Aug 9.
Abstract
摘要
相似文献
1
Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in Egypt.
Breast J. 2011 Sep-Oct;17(5):545-7. doi: 10.1111/j.1524-4741.2011.01146.x. Epub 2011 Aug 9.
2
Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
BMC Cancer. 2021 Feb 6;21(1):138. doi: 10.1186/s12885-021-07855-z.
3
Identifying factors that impact survival among women with inflammatory breast cancer.
Ann Oncol. 2012 Apr;23(4):870-5. doi: 10.1093/annonc/mdr319. Epub 2011 Jul 15.
4
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Breast Cancer Res Treat. 2015 Jul;152(2):407-16. doi: 10.1007/s10549-015-3436-x. Epub 2015 May 29.
5
Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
Oncotarget. 2017 Jul 25;8(30):49370-49379. doi: 10.18632/oncotarget.17217.
6
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort.
Lancet Oncol. 2014 May;15(6):640-7. doi: 10.1016/S1470-2045(14)70080-4. Epub 2014 Mar 20.
7
Inflammatory breast cancer outcomes by breast cancer subtype: a population-based study.
Future Oncol. 2019 Feb;15(5):507-516. doi: 10.2217/fon-2018-0677. Epub 2018 Oct 31.
8
Does age predict outcome in patients with inflammatory breast cancer?
Am Surg. 2014 Aug;80(8):E221-4.
9
A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer.
Breast. 2020 Oct;53:212-220. doi: 10.1016/j.breast.2020.08.006. Epub 2020 Aug 17.
10
Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences.
Oncology. 2010;79(1-2):105-11. doi: 10.1159/000320162. Epub 2010 Nov 22.
引用本文的文献
1
Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value.
Biomolecules. 2020 Jul 16;10(7):1059. doi: 10.3390/biom10071059.
2
Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-β-catenin signalling, the stem cell phenotype and disease progression.
J Adv Res. 2018 Dec 8;16:75-86. doi: 10.1016/j.jare.2018.11.006. eCollection 2019 Mar.
3
Considerations in setting up and conducting epidemiologic studies of cancer in middle- and low-income countries: the experience of a case-control study of inflammatory breast cancer in North Africa in the past 10 years.
Cancer Med. 2012 Dec;1(3):338-49. doi: 10.1002/cam4.36. Epub 2012 Oct 11.
4
Research training of students in minority and international settings: lessons learned from cancer epidemiology education in special populations.
J Cancer Educ. 2010 Jun;25(2):263-9. doi: 10.1007/s13187-010-0099-5. Epub 2010 Mar 30.
本文引用的文献
1
High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt.
Breast J. 2009 Jul-Aug;15(4):432-4. doi: 10.1111/j.1524-4741.2009.00755.x.
2
Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients.
Breast. 2009 Feb;18(1):55-9. doi: 10.1016/j.breast.2008.11.002. Epub 2009 Jan 20.
3
Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features.
Semin Oncol. 2008 Feb;35(1):17-24. doi: 10.1053/j.seminoncol.2007.11.017.
4
Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients.
Breast Cancer Res Treat. 2008 Nov;112(1):141-7. doi: 10.1007/s10549-007-9833-z. Epub 2007 Dec 4.
5
Trends for inflammatory breast cancer: is survival improving?
Oncologist. 2007 Aug;12(8):904-12. doi: 10.1634/theoncologist.12-8-904.
6
Epidemiology of inflammatory breast cancer (IBC).
Breast Dis. 2005;22:9-23. doi: 10.3233/bd-2006-22103.
7
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
J Natl Cancer Inst. 2005 Jul 6;97(13):966-75. doi: 10.1093/jnci/dji172.
8
Breast cancer in Egypt: a review of disease presentation and detection strategies.
East Mediterr Health J. 2003 May;9(3):448-63.
9
Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1128-35.
10
[Breast cancer in Tunisia: clinical and epidemiological study].
Bull Cancer. 1999 Mar;86(3):302-6.
Zotero 插件